FL H0095

Prohibits health insurance policies and HMO contracts from removing covered prescription drugs or reclassifying drugs to higher cost-sharing tiers during a policy/contract year, except when the FDA questions drug safety or the manufacturer discontinues production.

Allows insurers and HMOs to add new prescription drugs to formularies during the year and permits changes at the time of coverage renewal.

Requires small employer carriers to comply with the same prescription drug formulary restrictions as other insurers.

Exempts the state group insurance program, grandfathered health plans, and specific statutory benefits from these formulary change limitations.

Takes effect January 1, 2018.